Staar Surgical Co. logo

STAA

Staar Surgical Co.

$98.23

Earnings Summary

Revenue
$63.2Mn
Net Profits
$9.6Mn
Net Profit Margins
15.19%

Highlights

Revenue:

Staar Surgical Co.’s revenue jumped 24.53% since last year same period to $63.2Mn in the Q2 2022. On a quarterly growth basis, Staar Surgical Co. has generated 7.12% jump in its revenue since last 3-months.

Net Profits:

Staar Surgical Co.’s net profit jumped 92.35% since last year same period to $9.6Mn in the Q2 2022. On a quarterly growth basis, Staar Surgical Co. has generated 95.08% jump in its net profits since last 3-months.

Net Profit Margins:

Staar Surgical Co.’s net profit margin jumped 54.46% since last year same period to 15.19% in the Q2 2022. On a quarterly growth basis, Staar Surgical Co. has generated 82.12% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Staar Surgical Co. post its latest quarter earnings

EPS Estimate Current Quarter
0.16
EPS Estimate Current Year
0.16

Highlights

EPS Estimate Current Quarter:

Staar Surgical Co.’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a 100% jump from last quarter’s estimates.

EPS Estimate Current Year:

Staar Surgical Co.’s earning per share (EPS) estimates for the current year stand at 0.16.

Key Ratios

Key ratios of the Staar Surgical Co. post its Q2 2022 earnings

Earning Per Share (EPS)
0.19

Highlights

Earning Per Share (EPS):

Staar Surgical Co.’s earning per share (EPS) jumped 90% since last year same period to 0.19 in the Q2 2022. This indicates that the Staar Surgical Co. has generated 90% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-04
0.08
0.19
137.5%
2022-02-23
0.1
0.1
0%

Company Information

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.

Organisation
Staar Surgical Co.
Headquarters
Lake Forest, California, US
Employees
575
Industry
Health Technology
CEO
Caren Mason